- Technical Communications (OTC:TCCO) +260% after Q4 results.
- Equillium (EQ) +19% as itolizumab Fast Track'd for lupus nephritis.
- CounterPath (CPAH) +14% on the launch of Bria Solo.
- ObsEva SA (OBSV) +13% on positive linzagolix data.
- LMP Automotive Holdings (LMPX) +10%.
- Genworth Financial (GNW) +11% as Brookfield Business gets Canada's okay on Genworth MI Canada deal.
- Stitch Fix (SFIX) +9% after Q1 results.
- MongoDB (MDB) +8% after Q3 results.
- Dermira (DERM) +8% on receiving fast track designation from FDA for Lebrikizumab for the treatment of atopic dermatitis.
- Avid Bioservices (CDMO) +8% after Q2 results.
- Sibanye Gold (SBGL) +6%.
- Precision BioSciences (DTIL) +5%.
- Forty Seven (FTSV) +6%.